Analysts at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Price Performance Eagle Pharmaceuticals stock opened at $3.81 on Tuesday. Eagle Pharmaceuticals has a one year low of […]
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.47 and traded as low as $4.57. Eagle Pharmaceuticals shares last traded at $4.69, with a volume of 161,336 shares changing hands. Eagle Pharmaceuticals Stock Up 2.1 […]
Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Monday. Separately, Piper Sandler lowered Eagle Pharmaceuticals from a “neutral” rating to an “underweight” rating and decreased their target price for the stock from $26.00 to $17.00 […]
Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) issued an update on its FY23 earnings guidance on Thursday morning. The company provided EPS guidance of $4.40-4.70 for the period, compared to the consensus EPS estimate of $4.58. Eagle Pharmaceuticals Price Performance EGRX stock opened at $16.12 on Friday. The stock has a 50-day moving average price […]
Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Piper Sandler downgraded shares of Eagle Pharmaceuticals from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $26.00 […]